Prof. Jarosław Dastych, the President of the PhageEU coalition, is also the Founder, CEO, and Board President of Proteon Pharmaceuticals S.A. His passion for bacteriophage research and his understanding of bacteriophage technology as a promising alternative for addressing rising antimicrobial resistance (AMR) have driven his work to realise the full potential of phages. His research spans immunology, toxicology, molecular biology, and the development of bacteriophage-based treatments.

Over 18 years ago, he founded Proteon Pharmaceuticals, leading to the development of a unique bacteriophage platform technology. This innovation provides sustainable solutions for bacterial disease management in animal farming, aquaculture, and poultry production, earning international recognition and numerous innovation awards. Prof. Dastych has managed twelve European R&D projects, published over 70 scientific papers, and co-authored 13 biotechnology patents, highlighting his extensive expertise and dedication to scientific progress.